Loretta A Mullally, MD | |
5525 E Peck Rd, Croswell, MI 48422 | |
(810) 679-2950 | |
(810) 679-2960 |
Full Name | Loretta A Mullally |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 5525 E Peck Rd, Croswell, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467414227 | NPI | - | NPPES |
0762000 | Other | BCBSM | |
2684076 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | LM051024 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Loretta A Mullally, MD 5525 E Peck Rd, Croswell, MI 48422 Ph: (810) 679-2950 | Loretta A Mullally, MD 5525 E Peck Rd, Croswell, MI 48422 Ph: (810) 679-2950 |
News Archive
A burst appendix or a life-threatening intestinal volvulus are emergencies that need to be treated by surgeons immediately. However, a life-saving operation, in which tissue from the digestive tract has to be reattached, bears some risks. After all, everything that is transported through the gastrointestinal tract to the outside world in fact belongs there - and should under no circumstances end up inside the abdominal cavity.
Bavarian Nordic A/S announced today that PROSTVAC™ has been granted Fast Track designation by the U.S. Food & Drug Administration (FDA) for its proposed use in the treatment of men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).
Reaction Biology Corporation announced today that it has been awarded a Phase I SBIR grant from the National Center for Advancing Translational Sciences to create a database of epigenetic drug interactions.
Although it has become increasingly accepted for medical and recreational use, cannabis is still considered among one of the most widely used illegal substances in the United States and in many European countries.
Genzyme Corporation announced today that the company has ended fill/finish operations within its Allston plant for products sold in the United States, as required by the FDA consent decree.
› Verified 4 days ago